Insider track record Other Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Zeronda Tyler. Insider active across 1 company, notably VYNE Therapeutics Inc.. Cumulatively, 26 reports have been recorded. Activity tracked since 30 June 2021. The latest transaction was disclosed on 31 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations 26 total
8,399 shares @ US$1.58 24.8% of flow Common Stock SEC:0001415889-25-009633:0
4,675 shares @ US$3.35 30.4% of flow Common Stock SEC:0001415889-25-000156:0
84 shares @ US$1.88 0.3% of flow Common Stock SEC:0001415889-24-024383:0
92 shares @ US$1.92 0.3% of flow Common Stock SEC:0001415889-24-019176:0
94 shares @ US$3.08 0.5% of flow Common Stock SEC:0001415889-24-010074:0
62,500 shares 0Common Stock SEC:0001209191-24-000470:0
62,500 shares 0Common Stock SEC:0001209191-23-058819:0
1,087 shares @ US$3.83 8.0% of flow Common Stock SEC:0001209191-23-051960:0
91 shares @ US$4.10 0.7% of flow Common Stock SEC:0001209191-23-041139:0
384 shares @ US$3.08 2.2% of flow Common Stock SEC:0001209191-23-022806:0
354 shares @ US$0.15 0.1% of flow Common Stock SEC:0001209191-23-001081:0
353 shares @ US$0.223 0.2% of flow Common Stock SEC:0001209191-22-052359:0
354 shares @ US$0.389 0.3% of flow Common Stock SEC:0001209191-22-040789:0
12,510 shares @ US$0.3463 0.021% mcap 25.2% of flow Common Stock SEC:0001209191-22-033544:0
773 shares @ US$0.65 0.0024% mcap 2.8% of flow Common Stock SEC:0001209191-22-022532:0
75,000 shares 0Common Stock SEC:0001209191-22-020067:0
206 shares @ US$1.02 0.4% of flow Common Stock SEC:0001209191-22-000861
206 shares @ US$1.02 0.0010% mcap 1.2% of flow Common Stock SEC:0001209191-22-000861:0
4,187 shares @ US$0.8755 6.6% of flow Common Stock SEC:0001209191-21-067649
4,187 shares @ US$0.8755 0.017% mcap 20.3% of flow Common Stock SEC:0001209191-21-067649:0
206 shares @ US$1.39 0.0013% mcap 1.5% of flow Common Stock SEC:0001209191-21-058522:0
206 shares @ US$1.39 0.5% of flow Common Stock SEC:0001209191-21-058522
60,859 shares 0Common Stock SEC:0001209191-21-054837:0
60,859 shares 0Common Stock SEC:0001209191-21-054837
700 shares @ US$3.51 0.011% mcap 13.0% of flow Common Stock SEC:0001209191-21-044983:0
25 of 26 declarations
Load more (1 remaining) About Zeronda Tyler Zeronda Tyler is a director at VYNE Therapeutics Inc.